Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.
File Type:
PDFItem Type:
Journal ArticleDate:
2014Access:
openAccessCitation:
Mockler MB, Conroy MJ, Lysaght J, Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment., Frontiers in oncology, 4, 2014, 107Download Item:
Abstract:
The immune system has a key role to play in controlling cancer initiation and progression. T cell activation, which is central to anti-tumor immune responses, coincides with changes in cellular metabolism. Naïve T cells predominantly require an ATP generating metabolic profile, whereas proliferating effector T cells require anabolic metabolic profiles that promote rapid growth and proliferation. Furthermore, specific T cell subsets require distinct energetic and biosynthetic pathways to match their functional requirements. The often hostile tumor microenvironment can affect T cell immune responses by altering the resulting cellular metabolism. Tailoring immune responses by manipulating cellular metabolic pathways may provide an exciting new option for cancer immunotherapy. T cell responses might also be skewed via metabolic manipulation to treat the complications of obesity-associated inflammation, which is a rapidly growing global health problem and a major risk factor for many malignancies. In this review, the diverse metabolic requirements of T cells in anti-tumor immunity are discussed, as well as the profound influence of the tumor microenvironment and the possible avenues for manipulation to enhance anti-tumor immunity.
Sponsor
Grant Number
Health Research Board (HRB)
HRA_POR/2011/91
Author's Homepage:
http://people.tcd.ie/laoneillhttp://people.tcd.ie/jlysaght
http://people.tcd.ie/meconroy
Description:
PUBLISHEDType of material:
Journal ArticleCollections
Series/Report no:
Frontiers in oncology4
Availability:
Full text availableKeywords:
obesity, metabolic targeting agents, T cells, cancer, immunometabolismSubject (TCD):
Cancer , Immunology, Inflammation & InfectionDOI:
http://dx.doi.org/10.3389/fonc.2014.00107Source URI:
http://www.ncbi.nlm.nih.gov/pubmed/24904823ISSN:
2234-943XMetadata
Show full item recordLicences: